Search results
FDA panel backs Guardant’s blood test for colon cancer
MedTech Dive via Yahoo Finance· 14 hours agoDeliberations among the panelists, whose recommendations are non-binding, centered on concerns about...
Israel faces unprecedented challenges as legal and diplomatic pressure mounts
CNN via Yahoo News· 9 hours agoIt’s been a tumultuous month for Israel. Never before has the Jewish state come under such intense...
Bankrupt Express On Fast Track of Settling Leases
Sourcing Journal via Yahoo Finance· 7 hours agoWHP already owned the intellectual property. Combined, Simon and Brookfield have about 200 Express stores at their centers. They want the business to...
Evansville City Council comment ban draws ire as 'sad and disappointing'
Gannett via AOL· 11 hours agoHeronemus did not respond to requests for comment from the Courier & Press. The non-binding...
Martin Midstream mulls $3.05/unit buyout proposal By Investing.com
Investing.com· 8 hours agoMartin Midstream (NASDAQ:MMLP) Partners L.P. (NASDAQ:MMLP), a diversified energy company, disclosed...
Putin says legitimacy of Ukraine’s Zelenskiy is over
KFGO· 3 hours ago(Reuters) - Russian President Vladimir Putin said on Friday that Ukrainian President Volodymyr Zelenskiy had no legitimacy following the expiry of his...
German railway Deutsche Bahn picks top bidders for freight subsidiary
dpa international via Yahoo Finance· 13 hours agoThe potential bidders include private equity investors and companies from Europe and the Middle...
Anglo American rejects BHP’s third takeover proposal
Mining Technology via Yahoo Finance· 2 days agoAnglo American announced that its board has unanimously rejected BHP’s third unsolicited, non-binding takeover proposal. The latest proposal from BHP...
Guardant Stock Climbs As Cancer Test Strides Towards FDA Ok
The Wall Street Journal· 10 hours agoShares of Guardant Health were up 8% Friday morning after an advisory panel to the U.S. Food and...
Guardant Health Stock Jumps. Blood Test for Cancer Moves Toward FDA Approval.
Barrons.com· 8 hours agoThe test, Shield, is for people 45 and older who are at average risk for the disease, according to...